Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Corinne Beinat, PhD, BSc (Hons)

Stanford University School of Medicine

Presented in loving memory of Be Bold and Behold honorees Kathryn Petrides and Lisa M. Laudico

A Theranostic Strategy for Precision Imaging and Treatment of Metastatic Triple-Negative Breast cancer

Sanchita Bhatnagar, PhD

University of Virginia School of Medicine

Targeting the mechanisms of oncogenic TRIM37 in metastatic triple negative breast cancer

Stacy Blain, PhD

The Research Foundation of the State of New York, SUNY Downstate Medical Center

Presented by #LightUpMBC and Moore Fight Moore Strong in memory of Jessica Moore

p27Kip1: A game changing target in metastatic breast cancer

Elvin Blanco, PhD

Houston Methodist Research Institute

Presented by METAvivor’s community of followers on social media in honor of all of those touched by metastatic breast cancer

Mitochondrial biogenesis for T-cell priming and enhanced immunotherapy in metastatic breast cancer

Lucia Borriello, PhD

Albert Einstein College of Medicine

Presented by 2019 New York Fashion Week

Targeting the Mechanism of Re-Dissemination and Metastasis in Stage IV Breast Cancer

PAULA BOS, PhD

Virginia Commonwealth University

Regulatory T Cell Promotion of Brain Metastatic Processes

Rolf Brekken, PhD

UT Southwestern

Pleiotrophin as a driver of the immune metastatic niche

Andrew Brenner, MD, PhD

Mays Cancer Center

Presented In Memory of Tarah Harvey by Minneapolis Metsquerade

Permeability of Sacituzumab Govitecan in Breast Cancer Brain Metastases

Lisa Carey, MD

The University of North Carolina at Chapel Hill, Chapel Hill, NC

HARMONY: Harnessing the Analysis of RNA expression and Molecular subtype to Optimize Novel TherapY for metastatic breast cancer

Jennifer Caswell-Jin, MD

Stanford University School of Medicine

Presented by the Linda (LeClair) Sousa, A Better Dream Foundation in memory of Linda (LeClair) Sousa

Fibroblast growth factor receptor signaling and immune composition in estrogen receptor-positive metastatic breast cancer

Isaac Chan, MD, PhD

UT Southwestern Medical Center

Presented by #Lindasbug: A VW Beetle Fundraiser in Memory of Linda Kreizenbeck

Using natural killer cells to eliminate breast cancer metastases

Changyan Chen, PhD

Northeastern University, Boston

Presented by #LightUpMBC Ambassador Team In Memory of Jessica Moore

Repurposing Bryostatin-1 (a Protein Kinase C Inhibitor-Based Drug) for Treating Metastatic Breast Cancer